Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.57 |
| ▸ | BCL9 | O00512 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21449896 | 0.85 | MGLL (0.53) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL27838824 | 0.84 | MGLL (0.60) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL4882211 | 0.83 | MGLL (0.59) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL21449847 | 0.83 | MGLL (0.53) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL22840 | 0.81 | MGLL (0.48) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL11919307 | 0.80 | MGLL (0.64) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL3065302 | 0.80 | MGLL (0.60) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL17661807 | 0.79 | MGLL (0.71) | MGLLBCL9CTNNB1FAAHGAA | |
| 4-Nitrophenyl Ethylcarbamate SCHEMBL1695035 | 0.78 | MGLL (0.74) | MGLLBCL9CTNNB1FAAHGAA | |
| SCHEMBL18703462 | 0.77 | MGLL (0.78) | MGLLBCL9CTNNB1FAAHGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210299210-A2 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | BICYCLETX LIMITED (GB) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299210-A2 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | TIMCC, TAP1, CD81 | MGLL 4048/4885BCL9 173/4885CTNNB1 4000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.